SCHEMBL10127318

SCHEMBL10127318

c1ccc2c(c1)sc1c(-c3cccc4c(-c5nnc6c7ccccc7c7ccccc7n56)cccc34)cccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.43
PARP14 Q460N5 1/20 0.41
ALOX5 P09917 1/20 0.39
PRKDC P78527 6/20 0.38
PIK3CD O00329 2/20 0.36
PIK3CB P42338 2/20 0.36
HTT P42858 1/20 0.35
PAX8 Q06710 1/20 0.35
PDE2A O00408 5/20 0.34
PDE10A Q9Y233 4/20 0.34
BRD4 O60885 1/20 0.34
PIK3CA P42336 1/20 0.34
MTOR P42345 1/20 0.34
PIK3CG P48736 1/20 0.34
KCNH2 Q12809 1/20 0.34
BRDT Q58F21 1/20 0.34
MAPT P10636 1/20 0.33
CCNC P24863 1/20 0.32
CDK8 P49336 1/20 0.32
ADK P55263 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10127319 0.99 POLB (0.42) POLBPARP14ALOX5PRKDCPIK3CD
SCHEMBL10127332 0.95 POLB (0.43) POLBPARP14ALOX5PRKDCPIK3CD
SCHEMBL10127316 0.95 POLB (0.43) POLBPARP14ALOX5PRKDCPIK3CD
SCHEMBL10127338 0.90 POLB (0.42) POLBPARP14ALOX5PRKDCPIK3CD
SCHEMBL10127328 0.88 POLB (0.45) POLBPARP14ALOX5PRKDCPIK3CD
SCHEMBL515618 0.88 POLB (0.46) POLBPARP14ALOX5PRKDCPIK3CD
SCHEMBL10127327 0.87 POLB (0.46) POLBPARP14ALOX5PRKDCPIK3CD
SCHEMBL515047 0.86 POLB (0.53) POLBPARP14ALOX5PRKDCPIK3CD
SCHEMBL10127331 0.85 POLB (0.52) POLBPARP14ALOX5PRKDCPIK3CD
SCHEMBL10127329 0.83 POLB (0.47) POLBPARP14ALOX5PRKDCPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 POLB 3317/4885PARP14 1478/4885ALOX5 1457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.